Veterinary Oncology Market Research Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Oncology Market, By Therapy
7.1. Veterinary Oncology Market, By Therapy Type, 2020-2030
7.1.1. Surgery
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Radiology
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Chemotherapy
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Immunotherapy
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Others (Combination Therapy, Targeted Therapy)
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Veterinary Oncology Market, By Animal Type
8.1. Veterinary Oncology Market, By Animal Type, 2020-2030
8.1.1. Canine
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Feline
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Veterinary Oncology Market, By Cancer Type
9.1. Veterinary Oncology Market, By Cancer Type, 2020-2030
9.1.1. Lymphoma
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Mast Cell Cancer
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Mammary and Squamous Cell Cancer
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Others (Anal Sac Carcinoma)
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Veterinary Oncology Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.1.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.1.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.1.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.1.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.6.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.7.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.6.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.7.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.6.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.7.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.5.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.5.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
Chapter 11. Company Profiles
11.1. PetCure Oncology
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Elanco
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Accuray Incorporated
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Varian Medical Systems
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Zoetis
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Karyopharm Therapeutics, Inc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. One Health
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Regeneus Ltd
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers